Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | IGF1R | P08069 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11248095 | 0.94 | TYR (0.69) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL28793656 | 0.94 | TYR (0.69) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL5167885 | 0.94 | TYR (0.67) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL5168590 | 0.94 | TYR (0.61) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL4960416 | 0.94 | TYR (0.68) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL4959142 | 0.92 | TYR (0.71) | TYRHTTALOX15MEN1TP53 | |
| SCHEMBL4957861 | 0.92 | TYR (0.71) | TYRHTTALOX15MEN1TP53 | |
| SCHEMBL4961630 | 0.92 | TYR (0.71) | TYRHTTALOX15MEN1TP53 | |
| SCHEMBL4958674 | 0.92 | TYR (0.71) | TYRHTTALOX15MEN1TP53 | |
| SCHEMBL4960346 | 0.92 | TYR (0.71) | TYRHTTALOX15MEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107148433-A | Resole curable with functional polyester | 伊士曼化工公司 | 2017-09-08 | — | — | CN | claimed |
| EP-3212685-A1 | RESOLE PHENOLIC RESINS CURABLE WITH FUNCTIONAL POLYESTERS | Eastman Chemical Company (US) | 2017-09-06 | — | — | EP | claimed |
| WO-2016069572-A1 | RESOLE PHENOLIC RESINS CURABLE WITH FUNCTIONAL POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 2016-05-06 | — | — | WO | claimed |
| US-20160115347-A1 | RESOLE PHENOLIC RESINS CURABLE WITH FUNCTIONAL POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 2016-04-28 | — | — | US | claimed |
| CN-120118458-A | Curable composition, resin, and cured product | 东京应化工业株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-119937242-A | Photosensitive resin composition | 东京应化工业株式会社 | 2025-05-06 | — | — | CN | disclosed |
| CN-113337170-B | Curable composition, cured product, near infrared absorbing filter, and method for producing same | 东京应化工业株式会社 | 2024-04-05 | — | — | CN | disclosed |
| CN-117327362-A | Curable resin composition | 东京应化工业株式会社 | 2024-01-02 | — | — | CN | disclosed |
| CN-117215149-A | Photosensitive resin composition | 东京应化工业株式会社 | 2023-12-12 | — | — | CN | disclosed |
| CN-113387055-A | Film, method for producing film, and bag | 住友化学株式会社 | 2021-09-14 | — | — | CN | disclosed |
| CN-113337170-A | Curable composition, cured product, near-infrared absorption filter, and method for producing same | 东京应化工业株式会社 | 2021-09-03 | — | — | CN | disclosed |
| CN-102884089-B | Process for preparing telechelic polyolefins from terpene initiators | 雪佛龙奥伦耐有限责任公司 | 2018-02-23 | — | — | CN | disclosed |
| US-6664420-B2 | For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia | MAGNESIUM DIAGNOSTICS, INC. | 2003-12-16 | — | — | US | disclosed |
| EP-1355638-A2 | ANTAGONISTS OF THE MAGNESIUM BINDING DEFECT AS THERAPEUTIC AGENTS AND METHODS FOR TREATMENT OF ABNORMAL PHYSIOLOGICAL STATES | Magnesium Diagnostics, Inc. (US) | 2003-10-29 | — | — | EP | disclosed |
| CN-1405217-A | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL CO (JP) | 2003-03-26 | — | — | CN | disclosed |
| US-20030040625-A1 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states | MAGNESIUM DIAGNOSTICS, INC. | 2003-02-27 | — | — | US | disclosed |
| US-6455734-B1 | ADMINISTERING PHENYLGLYCINAMIDE(N-2,4-DIAMYLPENTANOIC ACID AMIDE) AS HYPOTENSIVE AGENTS FOR PROPHYLAXIS OF INSULIN RESISTANCE, ECLAMPSIA AND SENSITIVITY TO BLOOD METAL CONCENTRATIONS | MAGNESIUM DIAGNOSTICS, INC. | 2002-09-24 | — | — | US | disclosed |
| WO-2002011714-A2 | ANTAGONISTS OF THE MAGNESIUM BINDING DEFECT AS THERAPEUTIC AGENTS AND METHODS FOR TREATMENT OF ABNORMAL PHYSIOLOGICAL STATES | MAGNESIUM DIAGNOSTICS, INC. (US) | 2002-02-14 | — | — | WO | disclosed |
| EP-0149173-B1 | TRIBUTYLPHENOLETHER-GLYCIDYL-SULPHONATES, PROCESS FOR THEIR PREPARATION AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-04-08 | — | — | EP | disclosed |
| EP-0149173-A1 | Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040625-A1 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states | ECE1, PLPBP, ECE2 | TYR 4860/4885HTT 3426/4885NPC1 2173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.